Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06520306
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-07-21
Brief Title:
A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia Cognition and Hip Function Recovery in Patients Undergoing Hip Arthroplasty
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia Cognition and Hip Function Recovery in Patients Undergoing Hip Arthroplasty
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Total hip arthroplasty THA is a commonly used treatment for hip lesions but it is often accompanied by persistent pain after surgery which obviously affects the quality of life of patients so perfect postoperative analgesia is particularly important for the rapid recovery of patients Peripheral nerve blocks are often used as postoperative analgesia for THA and fascia iliaca compartment block FICB is the preferred nerve block for THA due to its good postoperative analgesic effect and fewer postoperative adverse reactions However the effect of nerve block with ropivacaine alone is short and the postoperative analgesia time is limited which seriously affects the patient39s surgical recovery Therefore prolonging the postoperative analgesic time is an urgent problem to be solved by FICB and some scholars recommend the combined use of local anesthetic adjuvants to prolong the block time which is an effective and safe method In this study a long-acting analgesic drug methylene blue was selected as an adjuvant for ropivacaine for FICB but there was no unified clinical standard for the postoperative analgesic concentration of methylene blue
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None